Chemical Compound Review:
AC1NR4TH N-butyl-11- [(8S,9S,13S,14S,17S)-3,17...
Synonyms:
- Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle. Musgrove, E.A., Wakeling, A.E., Sutherland, R.L. Cancer Res. (1989)
- Circumvention of doxorubicin resistance in multi-drug resistant human leukaemia and lung cancer cells by the pure antioestrogen ICI 164384. Hu, X.F., Nadalin, G., De Luise, M., Martin, T.J., Wakeling, A., Huggins, R., Zalcberg, J.R. Eur. J. Cancer (1991)
- Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta. Role of nuclear estrogen receptor and Ca2+ uptake. Freay, A.D., Curtis, S.W., Korach, K.S., Rubanyi, G.M. Circ. Res. (1997)
- Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong, Y., Ballejo, G., Murphy, L.C., Murphy, L.J. Cancer Res. (1992)
- Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Wilcken, N.R., Prall, O.W., Musgrove, E.A., Sutherland, R.L. Clin. Cancer Res. (1997)
- Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha. Brockdorff, B.L., Heiberg, I., Lykkesfeldt, A.E. Endocr. Relat. Cancer (2003)
- Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells. Wilcken, N.R., Sarcevic, B., Musgrove, E.A., Sutherland, R.L. Cell Growth Differ. (1996)
- Inhibition of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase by antiestrogens. Santner, S.J., Santen, R.J. J. Steroid Biochem. Mol. Biol. (1993)
- Synergism between a half-site and an imperfect estrogen-responsive element, and cooperation with COUP-TFI are required for estrogen receptor (ER) to achieve a maximal estrogen-stimulation of rainbow trout ER gene. Petit, F.G., Métivier, R., Valotaire, Y., Pakdel, F. Eur. J. Biochem. (1999)
- Novel antioestrogens without partial agonist activity. Wakeling, A.E., Bowler, J. J. Steroid Biochem. (1988)
- ER beta: identification and characterization of a novel human estrogen receptor. Mosselman, S., Polman, J., Dijkema, R. FEBS Lett. (1996)
- Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens. Coutts, A., Murphy, L.J., Murphy, L.C. Breast Cancer Res. Treat. (1994)
- Fibronectin is an estrogen-repressed protein in RUCA-I rat endometrial adenocarcinoma cells. Vollmer, G., Hopert, A.C., Ellerbrake, N., Wünsche, W., Knuppen, R. J. Steroid Biochem. Mol. Biol. (1995)
- The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines. Coradini, D., Biffi, A., Pirronello, E., Di Fronzo, G. Anticancer Res. (1995)
- Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor. Cormier, E.M., Jordan, V.C. European journal of cancer & clinical oncology. (1989)